Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Emory Brain Health Center, 12 Executive Park Drive, Atlanta, GA, 30322, USA.
Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Emory Brain Health Center, 12 Executive Park Drive, Atlanta, GA, 30322, USA.
J Affect Disord. 2021 Jul 1;290:197-201. doi: 10.1016/j.jad.2021.04.028. Epub 2021 Apr 25.
Bipolar Affective Disorder (BPAD) accounts for 10-25% of all mood disorders in the geriatric population and 5% of all inpatient admissions to geropsychiatric units. Electroconvulsive therapy (ECT) is an effective treatment for all phases of BPAD, though only a few studies have focused on BPAD in the geriatric population. This study examines the safety and efficacy of ultra-brief right unilateral (UBRUL) ECT for patients with late-life bipolar depression (BD).
A retrospective chart review was conducted of patients with late-life BD who received UBRUL ECT treatments. Symptomatic response was measured using pre- and post-ECT Quick Inventory of Depressive Symptomatology (QIDS-SR16) and Beck Depression Inventory (BDI-II) scores. Clinical improvement and cognitive change were measured using Clinical Global Impression-Improvement (CGI-I) and Electroconvulsive Cognitive Assessment (ECCA) scores.
Twenty-Seven elderly patients (mean age 69.1 ± 7.7 years) were included in the analysis. Baseline QIDS-SR16 was 17.3 ± 5.3 and BDI-II 30.0 ± 9.2. 80.0% (16/20) and 57.1% (4/7) of patients achieved response (50.0% decline) in their QIDS-SR16 and BDI-II scores, respectively. Remission rates in QIDS-SR16 (post-ECT scores ≤5) and BDI-II (post-ECT scores ≤12) were 65.0% (13/20) and 42.9% (3/7), respectively. Mean QIDS-SR16 and BDI-II scores were reduced by a statistically significant 68.2% and 50.5%, respectively (two-tailed, paired p-values <0.01) after ECT. CGI-I of ≤2 was attained by 85.2% (23/27) of patients. 85.7% (12/14) of patients saw no change or improvement in ECCA scores.
Inherent complications of chart review regarding quality, availability, and homogeny of data.
UBRUL ECT is a safe and effective treatment for patients presenting with late-life BD.
双相情感障碍(BPAD)占老年人群中所有情绪障碍的 10-25%,占老年精神科住院患者的 5%。电抽搐治疗(ECT)是治疗 BPAD 所有阶段的有效方法,尽管只有少数研究关注老年人群中的 BPAD。本研究检查了超短右单侧(UBRUL)ECT 治疗老年期双相抑郁(BD)患者的安全性和有效性。
对接受 UBRUL ECT 治疗的老年期 BD 患者进行回顾性图表审查。使用治疗前后的抑郁症状快速清单(QIDS-SR16)和贝克抑郁量表(BDI-II)评分来衡量症状反应。使用临床总体印象-改善(CGI-I)和电抽搐认知评估(ECCA)评分来衡量临床改善和认知变化。
共纳入 27 例老年患者(平均年龄 69.1 ± 7.7 岁)进行分析。基线 QIDS-SR16 为 17.3 ± 5.3,BDI-II 为 30.0 ± 9.2。QIDS-SR16(下降 50%)和 BDI-II(下降 50%)评分分别有 80.0%(16/20)和 57.1%(4/7)的患者达到反应。QIDS-SR16(ECT 后评分≤5)和 BDI-II(ECT 后评分≤12)的缓解率分别为 65.0%(13/20)和 42.9%(3/7)。ECT 后,QIDS-SR16 和 BDI-II 评分分别显著降低 68.2%和 50.5%(双侧,配对 p 值<0.01)。CGI-I≤2 的患者占 85.2%(23/27)。ECCA 评分无变化或改善的患者占 85.7%(12/14)。
图表审查固有的质量、可用性和数据一致性方面的并发症。
UBRUL ECT 是治疗老年期 BD 患者的一种安全有效的方法。